Systemic calcineurin inhibitors tacrolimus and voclosporin: a review of off-label dermatologic uses. (PubMed, J Am Acad Dermatol) - Jun 13, 2023 - "In comparison to cyclosporine, tacrolimus can be considered for treatment-refractory disease or in patients with cardiovascular risk factors or inflammatory bowel disease. Voclosporin has only been utilized in psoriasis currently, and clinical trials in psoriasis show voclosporin's efficacy. Voclosporin can be considered for patients with lupus nephritis."
Journal • Review • Atopic Dermatitis • Cardiovascular • Dermatitis • Dermatology • Gastroenterology • Gastrointestinal Disorder • Glomerulonephritis • Graft versus Host Disease • Immunology • Inflammation • Inflammatory Arthritis • Inflammatory Bowel Disease • Lupus • Lupus Nephritis • Nephrology • Psoriasis • Pyoderma Gangrenosum • Rare Diseases • Urticaria
|